EZH2 and diffuse large B-cell lymphoma: Consistently, an oncogenic role of EZH1/2, especially EZH2, has been well-documented because recurrent gain-of-function EZH2 mutations have been identified in 22% of diffuse large B-cell lymphomas and ~10% of follicular lymphomas39.